Microneedle‐Integrated Device for Transdermal Sampling and Analyses of Targeted Biomarkers

Currently available point‐of‐care systems for body fluid collection exhibit poor integration with sensors. Herein, the design of a disposable device for interstitial fluid (ISF) extraction as well as glucose, lactate, and potassium ion (K+) monitoring is reported on. It is minimally invasive and app...

Full description

Bibliographic Details
Main Authors: Shubhangi Shukla, Sina Azizi Machekposhti, Naveen Joshi, Pratik Joshi, Roger J. Narayan
Format: Article
Language:English
Published: Wiley-VCH 2023-06-01
Series:Small Science
Subjects:
Online Access:https://doi.org/10.1002/smsc.202200087
_version_ 1797799283009781760
author Shubhangi Shukla
Sina Azizi Machekposhti
Naveen Joshi
Pratik Joshi
Roger J. Narayan
author_facet Shubhangi Shukla
Sina Azizi Machekposhti
Naveen Joshi
Pratik Joshi
Roger J. Narayan
author_sort Shubhangi Shukla
collection DOAJ
description Currently available point‐of‐care systems for body fluid collection exhibit poor integration with sensors. Herein, the design of a disposable device for interstitial fluid (ISF) extraction as well as glucose, lactate, and potassium ion (K+) monitoring is reported on. It is minimally invasive and appropriate for single use, minimizing the risk of infection to the user. This microscale device contains a 3D‐printed cap‐like structure with a four‐by‐four microneedle (MN) array, bioreceptor‐modified carbon fiber (CF)‐sensing surface, and negative pressure convection technology. These features are incorporated within a compact, self‐contained, and manually operated microscale device, which is capable of withdrawing ≈3.0 μL of ISF from the skin. MN arrays applied with an upward driving force may increase the ISF flow rate. Moreover, functionalized CF working electrodes (WE1, WE2, WE3) are shown to selectively detect lactate, glucose, and K+ with high sensitivities of 0.258, 0.549, and 0.657 μA μm−1 cm−2 and low detection limits of 0.01, 0.080, 0.05 μm, respectively. Ex vivo testing on porcine skin is used to detect the ISF levels of the biomarkers. The microscale device can be a replacement for current point‐of‐care diagnostic approaches.
first_indexed 2024-03-13T04:16:34Z
format Article
id doaj.art-50f143e8cb8349f6b135d8260b473cf9
institution Directory Open Access Journal
issn 2688-4046
language English
last_indexed 2024-03-13T04:16:34Z
publishDate 2023-06-01
publisher Wiley-VCH
record_format Article
series Small Science
spelling doaj.art-50f143e8cb8349f6b135d8260b473cf92023-06-21T00:42:44ZengWiley-VCHSmall Science2688-40462023-06-0136n/an/a10.1002/smsc.202200087Microneedle‐Integrated Device for Transdermal Sampling and Analyses of Targeted BiomarkersShubhangi Shukla0Sina Azizi Machekposhti1Naveen Joshi2Pratik Joshi3Roger J. Narayan4Joint Department of Biomedical Engineering North Carolina State University Raleigh NC 27695-7907 USAJoint Department of Biomedical Engineering North Carolina State University Raleigh NC 27695-7907 USADepartment of Materials Science and Engineering North Carolina State University Raleigh NC 27695-7907 USADepartment of Materials Science and Engineering North Carolina State University Raleigh NC 27695-7907 USAJoint Department of Biomedical Engineering North Carolina State University Raleigh NC 27695-7907 USACurrently available point‐of‐care systems for body fluid collection exhibit poor integration with sensors. Herein, the design of a disposable device for interstitial fluid (ISF) extraction as well as glucose, lactate, and potassium ion (K+) monitoring is reported on. It is minimally invasive and appropriate for single use, minimizing the risk of infection to the user. This microscale device contains a 3D‐printed cap‐like structure with a four‐by‐four microneedle (MN) array, bioreceptor‐modified carbon fiber (CF)‐sensing surface, and negative pressure convection technology. These features are incorporated within a compact, self‐contained, and manually operated microscale device, which is capable of withdrawing ≈3.0 μL of ISF from the skin. MN arrays applied with an upward driving force may increase the ISF flow rate. Moreover, functionalized CF working electrodes (WE1, WE2, WE3) are shown to selectively detect lactate, glucose, and K+ with high sensitivities of 0.258, 0.549, and 0.657 μA μm−1 cm−2 and low detection limits of 0.01, 0.080, 0.05 μm, respectively. Ex vivo testing on porcine skin is used to detect the ISF levels of the biomarkers. The microscale device can be a replacement for current point‐of‐care diagnostic approaches.https://doi.org/10.1002/smsc.2022000873D printingdiffusionglucose monitoringinterstitial fluidsmicroneedle arraystransdermal
spellingShingle Shubhangi Shukla
Sina Azizi Machekposhti
Naveen Joshi
Pratik Joshi
Roger J. Narayan
Microneedle‐Integrated Device for Transdermal Sampling and Analyses of Targeted Biomarkers
Small Science
3D printing
diffusion
glucose monitoring
interstitial fluids
microneedle arrays
transdermal
title Microneedle‐Integrated Device for Transdermal Sampling and Analyses of Targeted Biomarkers
title_full Microneedle‐Integrated Device for Transdermal Sampling and Analyses of Targeted Biomarkers
title_fullStr Microneedle‐Integrated Device for Transdermal Sampling and Analyses of Targeted Biomarkers
title_full_unstemmed Microneedle‐Integrated Device for Transdermal Sampling and Analyses of Targeted Biomarkers
title_short Microneedle‐Integrated Device for Transdermal Sampling and Analyses of Targeted Biomarkers
title_sort microneedle integrated device for transdermal sampling and analyses of targeted biomarkers
topic 3D printing
diffusion
glucose monitoring
interstitial fluids
microneedle arrays
transdermal
url https://doi.org/10.1002/smsc.202200087
work_keys_str_mv AT shubhangishukla microneedleintegrateddevicefortransdermalsamplingandanalysesoftargetedbiomarkers
AT sinaazizimachekposhti microneedleintegrateddevicefortransdermalsamplingandanalysesoftargetedbiomarkers
AT naveenjoshi microneedleintegrateddevicefortransdermalsamplingandanalysesoftargetedbiomarkers
AT pratikjoshi microneedleintegrateddevicefortransdermalsamplingandanalysesoftargetedbiomarkers
AT rogerjnarayan microneedleintegrateddevicefortransdermalsamplingandanalysesoftargetedbiomarkers